Slides
Page 1
CSL Tim , patient living with Hemophilia A 2026 Full Year Results 18 August 2026 Gordon Naylor Interim Chief Executive Officer & Managing Director Ken Lim Chief Financial Officer
Loading workspace
CSL Tim , patient living with Hemophilia A 2026 Full Year Results 18 August 2026 Gordon Naylor Interim Chief Executive Officer & Managing Director Ken Lim Chief Financial Officer
Your watchlist and earnings event details are available after you sign in.